메뉴 건너뛰기




Volumn 8, Issue 5, 2005, Pages 105-107

Regulatory and experimental aspects of oxidative stress testing of pharmaceuticals

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG IMPURITY; DRUG OXIDATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; OXIDATIVE STRESS; PHOTOLYSIS;

EID: 33749349154     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (17)
  • 5
    • 33749352446 scopus 로고    scopus 로고
    • INDs for phase II and III studies of drugs, including specified therapeutic biotechnology derived products
    • INDs for Phase II and III Studies of Drugs, Including Specified Therapeutic Biotechnology Derived Products, (Federal Register Notices), 64(76):31224-31225 (1998).
    • (1998) Federal Register Notices , vol.64 , Issue.76 , pp. 31224-31225
  • 7
    • 0027935179 scopus 로고
    • Boccardi, G. IL Farmaco, 49(6): 431-435 (1994).
    • (1994) Il Farmaco , vol.49 , Issue.6 , pp. 431-435
    • Boccardi, G.1
  • 10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.